| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/05/2007 | CN100335053C Medicinal preparation and its preparing method |
| 09/05/2007 | CN100335036C Method and composition for dry eye treatment |
| 09/05/2007 | CN100335035C Medicament for ophthalmology |
| 09/04/2007 | US7265228 N-(alpha-methylolbenzyl)1-(aminoethyl)- or 1-(aminocarbonyl)-2-aryl(especially phenyl or benzodioxanyl)-2-hydroxyethylamine intermediates for enantiomeric synthesis of amino ceramide-like compounds |
| 09/04/2007 | US7265227 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 09/04/2007 | US7265150 E.g., [(2S)-1-(1,2-dioxo-3,3-dimethylpentyl)-2-hydroxymethylpyrrolidine; (2S)-1-(1, 2-dioxo-3,3-dimethylpentyl)-2-pyrrolidinetetrazole; (2S)-1-(1,2-dioxo-3,3-dimethylpentyl)-2-pyrrolidinecarbonitrile; and 2S)-1-(1,2-dioxo-3,3-dimethylpentyl)-2-aminocarbonyl piperidine |
| 09/04/2007 | US7265136 Substituted stilbene compounds with vascular damaging activity |
| 09/04/2007 | US7265119 For therapy of nicotine dependency |
| 09/04/2007 | US7265117 Contain a preservative ingredient consisting of a combination of polyquaternium-1 and boric acid, ophthalmic solution |
| 09/04/2007 | US7265113 Anticancer agents; antiinflammatory agents, for therapy of rheumatoid arthritis |
| 09/04/2007 | US7265108 For example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 09/04/2007 | US7265089 KGF polypeptide compositions |
| 08/30/2007 | WO2007097961A1 Use of azurocidin inhibitors in prevention and treatment of ocular vascular leakage |
| 08/30/2007 | WO2007097839A2 Ansamycin analogs or heat shock 90 inhibitors in combination with pdt treatin conditions of the eye |
| 08/30/2007 | WO2007097205A1 Eyedrops |
| 08/30/2007 | WO2007096859A2 Protection of the retina against laser injury by adnf peptides such as nap and sal |
| 08/30/2007 | WO2007096745A1 Methods for the treatment of macular degeneration and related eye conditions |
| 08/30/2007 | WO2007096744A1 Methods for the treatment of macular degeneration and related eye conditions |
| 08/30/2007 | WO2007096694A1 Combination of neuroactivating active principles |
| 08/30/2007 | WO2007053807A3 Calcitriol for treating intraocular diseases associated with angiogenesis |
| 08/30/2007 | WO2006119211A3 Methods and compositions for treating ocular disorders |
| 08/30/2007 | US20070203337 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 08/30/2007 | US20070203223 Via amino ceramide-like compounds; lowering glycosphingolipid concentrations; Fabry's disease, Gaucher's disease |
| 08/30/2007 | US20070203211 Drug for preventing or treating angiogenic eye diseases |
| 08/30/2007 | US20070203141 Method for administering birb 796 bs |
| 08/30/2007 | US20070202198 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors biofilters and bioreactors |
| 08/30/2007 | US20070202160 Solid-state form of celecoxib having enhanced bioavailability |
| 08/30/2007 | DE102006017679A1 Aerosol und Verwendungen desselben Aerosol and uses thereof |
| 08/30/2007 | CA2638827A1 Protection of the retina against laser injury by adnf peptides such as nap and sal |
| 08/29/2007 | EP1825855A1 Product containing prostaglandin having fluorine atom in molecule |
| 08/29/2007 | EP1423126B1 Treatment of hyperproliferative conditions of body surfaces |
| 08/29/2007 | EP1423125B1 Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma |
| 08/29/2007 | EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor |
| 08/29/2007 | EP1333840B9 M. tuberculosis chaperonin 60.1 and uses thereof |
| 08/29/2007 | EP1140078B1 Benzimidazole vascular damaging agents |
| 08/29/2007 | EP1105136B1 Method for treating ocular neovascular diseases |
| 08/29/2007 | EP1096932B1 Antihypertensive combination of valsartan and calcium channel blocker |
| 08/29/2007 | EP1024814B1 Use of antifungal agents for the topical treatment of fungus-induced mucositis |
| 08/29/2007 | CN101024627A Nitrogen-containing aromatic derivatives |
| 08/29/2007 | CN101024007A Micro-emulsion injecta containing houttuynia extract |
| 08/29/2007 | CN101023999A Chinese medicine composition and its preparing method and use |
| 08/29/2007 | CN101023945A Use of non-periphery substituted phthalocyaniu metal complex |
| 08/29/2007 | CN101023927A Stable eye lotion containing latanoprost as active ingredient |
| 08/29/2007 | CN100333724C Lomefloxacin eye gel |
| 08/28/2007 | US7262302 Antiinflammatory action; rheumatoid arthritis |
| 08/28/2007 | US7262203 For therapy of hyperproliferative diseases such as cancer or retinopathy; pazopanib and salts |
| 08/28/2007 | US7262201 Quinazoline derivatives |
| 08/28/2007 | US7262193 Triazaspiro[5.5]undecane derivative and pharmaceutical composition comprising the same as active ingredient |
| 08/28/2007 | CA2148253C Allergenic proteins and peptides from johnson grass pollen |
| 08/23/2007 | WO2007095486A1 Methods of treating blepharospasm using cyclosporine components |
| 08/23/2007 | WO2007094669A2 Composition used as a nutritional supplement and medication for the treatment of degenerative visual disorders and inflammation |
| 08/23/2007 | WO2007094423A1 Human monoclonal antibody capable of binding to human cytomegalovirus, and antigen-binding domain of the antibody |
| 08/23/2007 | WO2007094193A1 Anti-angiogenic agent, prophylactic or therapeutic agent for disease accompanied by angiogenesis, and food |
| 08/23/2007 | WO2007093656A1 Use of derivatives of naphthalenesulphonic or quinolinesulphonic acid in the treatment of vasoproliferative ocular diseases |
| 08/23/2007 | WO2007093183A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases |
| 08/23/2007 | WO2007054566A3 Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy |
| 08/23/2007 | WO2006097337A3 11β-HYDROXYSTEROID DEHYDROGENASES |
| 08/23/2007 | US20070197648 Pharmaceutical product containing tranilast |
| 08/23/2007 | US20070197602 Combined pharmaceutical composition |
| 08/23/2007 | US20070197570 Indanol derivative |
| 08/23/2007 | US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome |
| 08/23/2007 | US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient |
| 08/23/2007 | US20070197503 Solutions containing epinastin |
| 08/23/2007 | US20070197489 Composition of matter |
| 08/23/2007 | US20070197456 Preparation and diabetic use of Gibberellins |
| 08/23/2007 | US20070196857 Determination of risk and treatment of complications of prematurity |
| 08/23/2007 | CA2645734A1 Method of treating inflammatory diseases |
| 08/23/2007 | CA2642668A1 Indole-3-carboxylic acid amide and ester compounds bearing phenyl groups having sphingosine-1-phosphate (sip) receptor antagonist biological activity |
| 08/22/2007 | EP1820495A2 Microspheres for active embolization |
| 08/22/2007 | EP1820442A1 Noninvasive measurements of chemical substances |
| 08/22/2007 | EP1819670A1 12-aryl prostaglandin analogs |
| 08/22/2007 | EP1819366A1 A staining composition for staining an ophthalmic membrane |
| 08/22/2007 | EP1819362A2 Topical nepafenac formulations |
| 08/22/2007 | EP1572892A4 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 08/22/2007 | EP1499320B1 Novel compounds |
| 08/22/2007 | EP1467728B1 Pharmaceutical compositions comprising valsartan and nep inhibitors |
| 08/22/2007 | EP1453804B1 Ccr-3 receptor antagonists vii |
| 08/22/2007 | EP1448523B1 Heterocyclic compounds and methods of use |
| 08/22/2007 | EP1227813B1 REVERSE-TURN MIMETICS AS alpha 4ß INTEGRIN INHIBITORS |
| 08/22/2007 | EP1178952B1 Novel interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators |
| 08/22/2007 | EP1157040B1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 08/22/2007 | CN1332961C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 08/22/2007 | CN1332952C 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im |
| 08/22/2007 | CN1332714C Method for treating fibrosis by utilizing integrin alpha 4 subunit antagonist |
| 08/22/2007 | CN1332680C Formulation formula for treating acute-chronic purulent tympanitis |
| 08/22/2007 | CN101020659A 9-aminoalkylamido-1-azabenznthrone derivative and its synthesis and application |
| 08/22/2007 | CN101019967A Process of preparing antiviral medicine composition |
| 08/22/2007 | CN101019914A Soft capsule containing lutein and its prepn |
| 08/22/2007 | CN101019876A Compound roxithromycin dispersing tablet and its prepn |
| 08/21/2007 | US7259179 Kinase inhibitors |
| 08/21/2007 | US7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists |
| 08/21/2007 | US7259154 Pyrrolopyrimidines |
| 08/21/2007 | US7258872 Chromone enteric release formulation |
| 08/21/2007 | CA2387600C Novel fusidic acid derivatives |
| 08/16/2007 | WO2007092469A2 Combination of organic compounds |
| 08/16/2007 | WO2007092391A1 Androgen receptor modulators and methods of treating disease using the same |
| 08/16/2007 | WO2007092157A1 7-(1h-imidazol-4-yl) methyl) -5,6,7,8-tetrahydroquinoline |
| 08/16/2007 | WO2007091970A1 Novel method and compositions for treatment of tinnitus |
| 08/16/2007 | WO2007091570A1 Binding inhibitor of sphingosine-1-phosphate |
| 08/16/2007 | WO2007091396A1 Novel amidopropionic acid derivative and pharmaceutical product containing same |